In Vitro Activity of TD-6424 against Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 11, 2003, Pages 3602-3604

  Pace, John L ^a   Krause, Kevin ^a   Johnston, Deborah ^a   Debabov, Dmitri ^a   Wu, Terry ^a   Farrington, Lesley ^a   Lane, Cassie ^a   Higgins, Deborah L ^a   Christensen, Burt ^a   Judice, J Kevin ^a,b   Kaniga, Koné ^a  

^a THERAVANCE INC   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDE; LINEZOLID; NAFCILLIN; OXACILLIN; TEICOPLANIN; TELAVANCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 10744223657     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.11.3602-3604.2003     Document Type: Article

References (6)

1. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams and Wilkins, Baltimore, Md.
2. Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9:486-493.
3. Maranan, M. C., B. Moreira, S. Boyle-Vavra, and R. S. Daum. 1997. Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infect. Dis. Clin. N. Am. 11:813-849.
4. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved guideline 5th ed., M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. Panlilio, A. L., D. H. Culver, R. P. Gaynes, S. Banerjee, T. S. Henderson, J. S. Tolson, and W. J. Martone. 1992. Methicillin-resistant Staphylococcus aureus in U. S. hospitals, 1975-1991. Infect. Control. Hosp. Epidemiol. 13:582-586.